Variability in total serum IgE over 1 year in severe asthmatics.
Asthma
IgE
Variability
Journal
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
ISSN: 1710-1484
Titre abrégé: Allergy Asthma Clin Immunol
Pays: England
ID NLM: 101244313
Informations de publication
Date de publication:
2019
2019
Historique:
received:
05
06
2018
accepted:
04
03
2019
entrez:
13
4
2019
pubmed:
13
4
2019
medline:
13
4
2019
Statut:
epublish
Résumé
Immunoglobulin E (IgE) is the treatment target of omalizumab, a monoclonal antibody indicated in the treatment of severe allergic asthma. Long-term variability of serum total IgE (sIgE In this prospective study, sIgE The variation in sIgE In severe asthmatics, limited within-patient variability of sIgE
Sections du résumé
BACKGROUND
BACKGROUND
Immunoglobulin E (IgE) is the treatment target of omalizumab, a monoclonal antibody indicated in the treatment of severe allergic asthma. Long-term variability of serum total IgE (sIgE
METHODS
METHODS
In this prospective study, sIgE
RESULTS
RESULTS
The variation in sIgE
CONCLUSION
CONCLUSIONS
In severe asthmatics, limited within-patient variability of sIgE
Identifiants
pubmed: 30976287
doi: 10.1186/s13223-019-0331-8
pii: 331
pmc: PMC6441212
doi:
Types de publication
Journal Article
Langues
eng
Pagination
20Déclaration de conflit d'intérêts
GB, RL, AM, OM and CP are members of an Advisory Board of Novartis Pharma, Belgium. IA and KD work for Matrix45, LLC. By company policy employees are prohibited from owning equity in or perform services independently for sponsor organizations. Matrix45 provides similar services to other biopharmaceutical on a non-exclusivity basis. SG, AP, JVS and SV are employees of Novartis Pharma, Belgium.
Références
J Allergy Clin Immunol. 2001 Apr;107(4):686-92
pubmed: 11295659
Immunity. 2001 Jun;14(6):791-800
pubmed: 11420048
Immunity. 2001 Jun;14(6):801-11
pubmed: 11420049
Annu Rev Immunol. 2003;21:579-628
pubmed: 12500981
Allergy. 2005 Mar;60(3):309-16
pubmed: 15679715
Respir Med. 2005 May;99(5):553-8
pubmed: 15823451
Can Respir J. 2006 Jul-Aug;13 Suppl B:1B-9B
pubmed: 16909166
J Allergy Clin Immunol. 2007 Jan;119(1):213-8
pubmed: 17208604
Respir Med. 2007 Jul;101(7):1483-92
pubmed: 17339107
Ann Allergy Asthma Immunol. 2008 Apr;100(4):392-5
pubmed: 18450128
Am J Respir Crit Care Med. 2011 Jul 15;184(2):206-14
pubmed: 21474647
J Asthma. 2012 Mar;49(2):115-20
pubmed: 22277088
Am J Respir Crit Care Med. 2013 Apr 15;187(8):804-11
pubmed: 23471469
PLoS One. 2013;8(3):e58388
pubmed: 23555579
Eur Respir J. 2014 Feb;43(2):343-73
pubmed: 24337046
Eur Respir J. 2014 Jul;44(1):97-108
pubmed: 24525441
J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):691-696.e1
pubmed: 27039239
Int J Clin Pract. 2016 Jul;70(7):596-605
pubmed: 27352803
Am J Respir Crit Care Med. 2017 Feb 1;195(3):302-313
pubmed: 27556234
J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1335-1343.e5
pubmed: 28389300
J Allergy Clin Immunol. 1987 Jun;79(6):919-27
pubmed: 3584747
J Allergy Clin Immunol. 1994 Dec;94(6 Pt 1):954-62
pubmed: 7798543
Science. 1994 Jun 24;264(5167):1876-7
pubmed: 8009216